From August 16, 2023 to September 30, 2023, the company has repurchased 400,000 shares, representing 0.51% for CNY 22.64 million. With this, the company has completed the repurchase of 400,000 shares, representing 0.51% for CNY 22.64 million under the buyback announced on August 17, 2023.
Hangzhou Alltest Biotech Co., Ltd.
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.18 CNY | +0.47% | +1.40% | -16.65% |
Apr. 29 | China, HK stocks rise, led by property shares | RE |
Apr. 26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-16.65% | 612M | |
-5.82% | 12.1B | |
-2.83% | 8.24B | |
+6.33% | 5.82B | |
+29.77% | 5.58B | |
-9.12% | 4.15B | |
-59.98% | 2.68B | |
+9.11% | 2.63B | |
+17.24% | 2.03B | |
-7.99% | 1.79B |
- Stock Market
- Equities
- 688606 Stock
- News Hangzhou Alltest Biotech Co., Ltd.
- Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.